Princeton, NJ, April 7, 2010 -Sandoz Inc. announced today the introduction in the US of losartan potassium and losartan potassium-hydrochlorothiazide (HCTZ) tablets, authorized generic equivalents of ...

Daiichi Sankyo has presented new data showing that Benicar is superior to Merck & Co's now off-patent Cozaar in reducing blood pressure. Daiichi Sankyo has presented new data showing that Benicar is ...

Jerusalem, March 2, 2010- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning ...

Teva Pharmaceutical Industries has been given the go-ahead in the USA for its generic versions of Merck & Co's blockbuster antihypertensives Cozaar and Hyzaar. Teva Pharmaceutical Industries has been ...

BALTIMORE, Md. Lupin Pharmaceuticals received regulatory approval last week for its generic antihypertensive agents, the drug maker said. Lupin was granted final approval for ...

Review the side-effects of Losartan as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...